A. Ahmed, S. Razzaque, S. Shetty, and Z. S. Kaveri, Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up, Journal of the American Academy of Dermatology, vol.74, issue.4, pp.700-708
DOI : 10.1016/j.jaad.2015.11.030

J. H. Anolik, J. Barnard, and T. Owen, Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis & Rheumatism, vol.8, issue.9, pp.3044-3056, 2007.
DOI : 10.4049/jimmunol.165.10.5558

P. D. Collins, S. Marleau, D. A. Griffiths-johnson, P. J. Jose, and T. J. Williams, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, Journal of Experimental Medicine, vol.182, issue.4, pp.1169-1174, 1995.
DOI : 10.1084/jem.182.4.1169

N. Colliou, D. Picard, and F. Caillot, 2013 Long-Term Remissions of Severe Pemphigus after Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.5, issue.175, pp.175-205

O. G. Dimson, J. George, C. L. Giudice, and . Fu, Identification of a Potential Effector Function for IgE Autoantibodies in the Organ-Specific Autoimmune Disease Bullous Pemphigoid, Journal of Investigative Dermatology, vol.120, issue.5, pp.784-788, 2003.
DOI : 10.1046/j.1523-1747.2003.12146.x

J. Elsner, H. Petering, and C. Kluthe, Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils, European Journal of Immunology, vol.260, issue.7, pp.2152-2158, 1998.
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G

D. Frasca, A. M. Landin, R. L. Riley, and B. B. Blomberg, Mechanisms for Decreased Function of B Cells in Aged Mice and Humans, The Journal of Immunology, vol.180, issue.5, pp.2741-2746, 1950.
DOI : 10.4049/jimmunol.180.5.2741

I. Hall, R. P. Robert, D. Streilein, and D. L. Hannah, Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients, Journal of Investigative Dermatology, vol.133, issue.12, pp.2786-2788
DOI : 10.1038/jid.2013.236

F. Iannone, M. Tampoia, and M. Giannini, 2016 Changes in Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor Isotypes Serum Levels in Patients with Rheumatoid Arthritis Following Treatment with Different Biological Drugs, Clinical and Experimental Rheumatology, vol.34, issue.3, pp.424-429

P. Joly, Incidence of bullous pemphigoid and pemphigus vulgaris, BMJ, vol.337, issue.jul09 1, p.209, 2008.
DOI : 10.1136/bmj.a209

P. Joly, J. Roujeau, and J. Benichou, A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-327
DOI : 10.1056/NEJMoa011592

P. Joly, P. Bernard, and C. Bedane, 2011 [Pemphigus. Guidelines for the diagnosis and treatment, pp.252-258

M. Kasperkiewicz, I. Shimanovich, and R. J. Ludwig, Rituximab for Treatment-Refractory Pemphigus and Pemphigoid: A Case Series, p.17, 2011.

S. M. Langan, L. Smeeth, and R. Hubbard, Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study, BMJ, vol.337, issue.jul09 1, p.180, 2008.
DOI : 10.1136/bmj.a180

Y. Lee and . Ho, Sang-Cheol Bae, and Gwan Gyu Song 2011 The Efficacy and Safety of Rituximab for the Treatment of Active Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Rheumatology International, issue.11, pp.31-1493

J. Lemaoult, P. Szabo, and M. E. Weksler, Selection of the B-Cell Repertoire and B-Cell Development, Effect of Age on Humoral Immunity Immunological Reviews, vol.160, pp.115-126, 1997.

Q. Li, H. Ujiie, and A. Shibaki, Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model, The Journal of Immunology, vol.185, issue.12, pp.185-7746, 1950.
DOI : 10.4049/jimmunol.1000667

Z. Liu, L. A. Diaz, and S. J. Swartz, Molecular Mapping of a Pathogenically Relevant BP180 Epitope Associated with Experimentally Induced Murine Bullous Pemphigoid, Journal of Immunology, issue.11, pp.155-5449, 1950.

F. E. Lund, Cytokine-producing B lymphocytes?key regulators of immunity, Current Opinion in Immunology, vol.20, issue.3, pp.332-338, 2008.
DOI : 10.1016/j.coi.2008.03.003

V. Luu and M. I. Phi, B cells participate in tolerance and autoimmunity through cytokine production, Autoimmunity, vol.45, issue.1, pp.1-12
DOI : 10.3109/08916934.2012.665527

M. A. Maurer, G. Rakocevic, and C. S. Leung, Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity, Journal of Clinical Investigation, vol.122, issue.4, pp.1393-1402
DOI : 10.1172/JCI58743DS1

M. A. Maurer, F. Tuller, and V. Gredler, Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination, Journal of Neuroimmunology, vol.290, pp.49-53
DOI : 10.1016/j.jneuroim.2015.11.006

H. Mouquet, P. Musette, and M. Gougeon, B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses, Journal of Investigative Dermatology, vol.128, issue.12, pp.2859-2869, 2008.
DOI : 10.1038/jid.2008.178

M. Nakou, G. Katsikas, and P. Sidiropoulos, Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response, Arthritis Research & Therapy, vol.11, issue.4, p.131, 2009.
DOI : 10.1186/ar2798

. Anti-cd20, Therapy in Patients with Rheumatoid Arthritis: Predictors of Response and B Cell Subset Regeneration after Repeated Treatment, Arthritis and Rheumatism, vol.58, issue.6, pp.1566-1575

A. Roussel, J. Benichou, and Z. Arivelo-randriamanantany, Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.293-298, 2011.
DOI : 10.1001/archdermatol.2011.21

. Thèse-de-recherche-nicolas-berkani and . Schmidt, Enno, and Detlef Zillikens 2011 Diagnosis and Treatment of Patients with Autoimmune Bullous Disorders in Germany, Dermatologic Clinics, vol.29, issue.4, pp.663-671

E. Schmidt, K. Obe, E. B. Bröcker, and D. , Zillikens 2000 Serum Levels of Autoantibodies to BP180 Correlate with Disease Activity in Patients with Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, pp.174-178

S. Shetty and A. , Razzaque Ahmed 2013 Treatment of Bullous Pemphigoid with Rituximab: Critical Analysis of the Current Literature, Journal of Drugs in Dermatology: JDD, vol.12, issue.6, pp.672-677

J. Yamagami, A. S. Payne, and S. Kacir, Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity, Journal of Clinical Investigation, vol.120, issue.11, pp.4111-4117
DOI : 10.1172/JCI44425

D. Zillikens, P. A. Rose, and S. D. Balding, Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-579, 1997.
DOI : 10.1111/1523-1747.ep12337492

A. Ahmed, S. Razzaque, S. Shetty, and Z. S. Kaveri, Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up, Journal of the American Academy of Dermatology, vol.74, issue.4, pp.700-708
DOI : 10.1016/j.jaad.2015.11.030

W. Alduaij and T. M. Illidge, The future of anti-CD20 monoclonal antibodies: are we making progress?, Blood, vol.117, issue.11, pp.2993-3001, 2011.
DOI : 10.1182/blood-2010-07-298356

D. Allman and J. P. Miller, B cell development and receptor diversity during aging, Current Opinion in Immunology, vol.17, issue.5, pp.463-467, 2005.
DOI : 10.1016/j.coi.2005.07.002

M. Amagai, K. Tsunoda, D. Zillikens, T. Nagai, and T. Nishikawa, The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile, Journal of the American Academy of Dermatology, vol.40, issue.2, pp.167-170, 1999.
DOI : 10.1016/S0190-9622(99)70183-0

D. Anand, U. Kumar, M. Kanjilal, S. Kaur, and N. Das, CD35) Transcript and Its Correlation with the Clinical Disease Activity in Rheumatoid Arthritis Patients, Leucocyte Complement Receptor Clinical and Experimental Immunology, vol.1, issue.1763, pp.327-335, 2014.

G. J. Anhalt, S. C. Kim, and J. R. Stanley, Paraneoplastic Pemphigus, New England Journal of Medicine, vol.323, issue.25, pp.1729-1735, 1990.
DOI : 10.1056/NEJM199012203232503

G. J. Anhalt, G. O. Till, and L. A. Diaz, Defining the Role of Complement in Experimental Pemphigus Vulgaris in Mice, Journal of Immunology, vol.137, issue.9, pp.2835-2840, 1950.

J. H. Anolik, J. Barnard, and T. Owen, Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis & Rheumatism, vol.8, issue.9, pp.3044-3056, 2007.
DOI : 10.4049/jimmunol.165.10.5558

W. P. Arend, The balance between IL-1 and IL-1Ra in disease, Cytokine & Growth Factor Reviews, vol.13, issue.4-5, pp.4-5, 2002.
DOI : 10.1016/S1359-6101(02)00020-5

V. Arora, R. Grover, A. Kumar, D. Anand, and N. Das, Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: A follow-up study, Lupus, vol.151, issue.10, pp.1010-1018, 2011.
DOI : 10.1038/ni1113

M. Auriemma, T. Brzoska, and L. Klenner, ??-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation, Journal of Investigative Dermatology, vol.132, issue.7, pp.1814-1824
DOI : 10.1038/jid.2012.59

URL : http://doi.org/10.1038/jid.2012.59

A. Baroni, A. Lanza, and N. Cirillo, Vesicular and Bullous Disorders: Pemphigus, Dermatologic Clinics, vol.25, issue.4, pp.597-603, 2007.
DOI : 10.1016/j.det.2007.07.001

P. A. Blair, F. Lina-yassin-noreña, and . Flores-borja, CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients, Immunity, vol.32, issue.1, pp.129-140, 2010.
DOI : 10.1016/j.immuni.2009.11.009

M. Borde, R. A. Barrington, V. Heissmeyer, M. C. Carroll, and A. , Transcriptional basis of lymphocyte tolerance, Immunological Reviews, vol.272, issue.1, pp.105-119, 2006.
DOI : 10.1016/S1074-7613(01)00085-1

J. Bouaziz, S. Calbo, and M. Maho-vaillant, IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro, European Journal of Immunology, vol.40, issue.10, pp.2686-2691, 2010.
DOI : 10.1002/eji.200940288

K. D. Brown, E. Claudio, and U. Siebenlist, The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis, Arthritis Research & Therapy, vol.10, issue.4, p.212, 2008.
DOI : 10.1186/ar2457

N. A. Carter, R. Vasconcellos, and E. C. Rosser, Mice Lacking Endogenous IL-10-Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells, The Journal of Immunology, vol.186, issue.10, pp.186-5569, 1950.
DOI : 10.4049/jimmunol.1100284

F. Chasset, A. De-masson, and H. L. Buanec, APRIL levels are associated with disease activity in human chronic graft-versus-host disease, Haematologica, vol.101, issue.7, pp.312-315
DOI : 10.3324/haematol.2016.145409

M. Cho, A. S. Jeffrey, X. Lo, and . Mao, 2014 Shared VH1-46 Gene Usage by Pemphigus Vulgaris Autoantibodies Indicates Common Humoral Immune Responses among Patients, Nature Communications, vol.5, p.4167
DOI : 10.1038/ncomms5167

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120239

P. D. Collins, S. Marleau, D. A. Griffiths-johnson, P. J. Jose, and T. J. Williams, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, Journal of Experimental Medicine, vol.182, issue.4, pp.1169-1174, 1995.
DOI : 10.1084/jem.182.4.1169

N. Colliou, D. Picard, and F. Caillot, 2013 Long-Term Remissions of Severe Pemphigus after Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.5, issue.175, pp.175-205

M. Demetriou, M. Granovsky, S. Quaggin, and J. W. , Dennis 2001 Negative Regulation of T-Cell Activation and Autoimmunity by Mgat5 N-Glycosylation, Nature, vol.409, issue.6821, pp.733-739
DOI : 10.1038/35055582

J. E. Dent and C. , From desk to bed: Computational simulations provide indication for rheumatoid arthritis clinical trials, BMC Systems Biology, vol.7, issue.1, p.10, 2013.
DOI : 10.1186/1752-0509-7-10

. Thèse-de-recherche-nicolas-berkani-dimson, G. Otobia, J. George, C. L. Giudice, and . Fu, Identification of a Potential Effector Function for IgE Autoantibodies in the Organ-Specific Autoimmune Disease Bullous Pemphigoid, The Journal of Investigative Dermatology, vol.120, issue.5, pp.784-788, 2003.

Q. Ding, M. Yeung, and G. Camirand, Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice, Journal of Clinical Investigation, vol.121, issue.9, pp.3645-3656, 2011.
DOI : 10.1172/JCI46274DS1

J. Elsner, H. Petering, and C. Kluthe, Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils, European Journal of Immunology, vol.260, issue.7, pp.2152-2158, 1998.
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G

A. Erdei, A. Isaák, and K. Török, Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions, Molecular Immunology, vol.46, issue.14, pp.2767-2773, 2009.
DOI : 10.1016/j.molimm.2009.05.181

J. G. Evans, A. Karina, A. Chavez-rueda, and . Eddaoudi, Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis, The Journal of Immunology, vol.178, issue.12, pp.7868-7878, 1950.
DOI : 10.4049/jimmunol.178.12.7868

J. A. Fairley, T. Christopher, C. Burnett, and . Fu, A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu Mice, Journal of Investigative Dermatology, vol.127, issue.11, pp.2605-2611, 2007.
DOI : 10.1038/sj.jid.5700958

J. A. Fairley, L. Chang, G. J. Fu, and . Giudice, Mapping the Binding Sites of Anti-BP180 Immunoglobulin E Autoantibodies in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.125, issue.3, pp.467-472, 2005.
DOI : 10.1111/j.0022-202X.2005.23853.x

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nature Immunology, vol.3, issue.10, pp.944-950, 2002.
DOI : 10.1038/ni833

D. Frasca, A. M. Landin, R. L. Riley, and B. B. Blomberg, Mechanisms for Decreased Function of B Cells in Aged Mice and Humans, The Journal of Immunology, vol.180, issue.5, pp.2741-2746, 1950.
DOI : 10.4049/jimmunol.180.5.2741

K. Friebel, R. Schönherr, and R. W. , Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients, Journal of Cellular Physiology, vol.3, issue.7, pp.1677-1688
DOI : 10.1186/ar142

D. Gay, T. Saunders, S. Camper, and M. Weigert, Receptor editing: an approach by autoreactive B cells to escape tolerance, Journal of Experimental Medicine, vol.177, issue.4, pp.999-1008, 1993.
DOI : 10.1084/jem.177.4.999

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190958/pdf

C. C. Goodnow, J. Crosbie, and S. Adelstein, Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice, Nature, vol.334, issue.6184, pp.676-682, 1988.
DOI : 10.1038/334676a0

F. Hagemeister, Rituximab for the Treatment of Non-Hodgkin?s Lymphoma and Chronic Lymphocytic Leukaemia, Drugs, vol.27, issue.8, pp.261-272, 2010.
DOI : 10.1016/S0140-6736(96)91681-5

I. Hall, R. P. Robert, D. Streilein, and D. L. Hannah, Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients, Journal of Investigative Dermatology, vol.133, issue.12, pp.2786-2788
DOI : 10.1038/jid.2013.236

X. He, K. Park, and J. Dietmar, The Role of ThPOK in Control of CD4/CD8 Lineage Commitment, Annual Review of Immunology, vol.28, issue.1, pp.295-320
DOI : 10.1146/annurev.immunol.25.022106.141715

S. Hiroyasu, T. Ozawa, and H. Kobayashi, Bullous Pemphigoid IgG Induces BP180 Internalization via?a Macropinocytic Pathway, The American Journal of Pathology, vol.182, issue.3, pp.828-840
DOI : 10.1016/j.ajpath.2012.11.029

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590760

F. Iannone, M. Tampoia, and M. Giannini, 2016 Changes in Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor Isotypes Serum Levels in Patients with Rheumatoid Arthritis Following Treatment with Different Biological Drugs, Clinical and Experimental Rheumatology, vol.34, issue.3, pp.424-429

R. Iorio and V. Damato, Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis, Journal of Neurology, vol.4, issue.7, pp.1115-1119
DOI : 10.3389/fimmu.2013.00494

Y. Iwata, T. Matsushita, and M. Horikawa, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-541, 2011.
DOI : 10.1182/blood-2010-07-294249

C. A. Janeway, C. C. Goodnow, and R. Medzhitov, Immunological tolerance: Danger ?? pathogen on the premises!, Danger -Pathogen on the Premises! Immunological Tolerance, pp.519-522, 1996.
DOI : 10.1016/S0960-9822(02)00531-6

P. Joly, Incidence of bullous pemphigoid and pemphigus vulgaris, BMJ, vol.337, issue.jul09 1, p.209, 2008.
DOI : 10.1136/bmj.a209

. Pemphigus, Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immu !, pp.252-258

S. M. Thèse-de-recherche-nicolas-berkani-kahan, E. J. Wherry, and A. J. , Zajac 2015 T Cell Exhaustion during Persistent Viral Infections, Virology, pp.479-480

M. Kasperkiewicz, I. Shimanovich, and R. J. Ludwig, Rituximab for Treatment-Refractory Pemphigus and Pemphigoid: A Case Series, p.17, 2011.
DOI : 10.1016/j.jaad.2010.07.032

S. I. Katz, D. Parker, and J. L. , B-cell suppression of delayed hypersensitivity reactions, Nature, vol.248, issue.5475, pp.550-551
DOI : 10.1159/000229624

M. E. Keir, J. Manish, G. J. Butte, A. H. Freeman, and . Sharpe, PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090331

C. Koc, N. Kaya, and . Sallakci, Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey, International Journal of Dermatology, vol.15, issue.1, pp.53-58
DOI : 10.1006/jaut.2000.0388

P. J. Koch, M. G. Mahoney, and H. Ishikawa, Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris, The Journal of Cell Biology, vol.12, issue.5, pp.1091-1102, 1997.
DOI : 10.1128/MCB.14.4.2404

G. Köhler and C. , Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-497
DOI : 10.1042/bj1280427

S. M. Langan, L. Smeeth, and R. Hubbard, Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study, BMJ, vol.337, issue.jul09 1, p.180, 2008.
DOI : 10.1136/bmj.a180

E. Lazzari and C. A. , IRF5-mediated signaling and implications for SLE, Clinical Immunology, vol.153, issue.2, pp.343-352
DOI : 10.1016/j.clim.2014.06.001

M. J. Leandro, G. Cambridge, J. C. Edwards, M. R. Ehrenstein, and D. A. , Isenberg 2005 B-Cell Depletion in the Treatment of Patients with Systemic Lupus Erythematosus: A Longitudinal Analysis of 24 Patients, Rheumatology, issue.12, pp.44-1542

Y. Lee and . Ho, Sang-Cheol Bae, and Gwan Gyu Song 2011 The Efficacy and Safety of Rituximab for the Treatment of Active Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Rheumatology International, issue.11, pp.31-1493

J. Lemaoult, P. Szabo, and M. E. Weksler, Selection of the B-Cell Repertoire and B-Cell Development, Effect of Age on Humoral Immunity Immunological Reviews, vol.160, pp.115-126, 1997.

H. Li, L. M. Ayer, and M. J. Polyak, The CD20 Calcium Channel Is Localized to Microvilli and Constitutively Associated with Membrane Rafts, Journal of Biological Chemistry, vol.27, issue.19, pp.19893-19901, 2004.
DOI : 10.1083/jcb.121.5.1121

W. Lin, D. Cerny, and E. Chua, Human Regulatory B Cells Combine Phenotypic and Genetic Hallmarks with a Distinct Differentiation Fate, The Journal of Immunology, vol.193, issue.5, pp.2258-2266, 1950.
DOI : 10.4049/jimmunol.1303214

Q. Li, H. Ujiie, and A. Shibaki, Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model, The Journal of Immunology, vol.185, issue.12, pp.185-7746, 1950.
DOI : 10.4049/jimmunol.1000667

Z. Liu, L. A. Diaz, and S. J. Swartz, Molecular Mapping of a Pathogenically Relevant BP180 Epitope Associated with Experimentally Induced Murine Bullous Pemphigoid, Journal of Immunology, issue.11, pp.155-5449, 1950.

F. E. Lund, Cytokine-producing B lymphocytes???key regulators of immunity, Current Opinion in Immunology, vol.20, issue.3, pp.332-338, 2008.
DOI : 10.1016/j.coi.2008.03.003

V. Luu and M. I. Phi, B cells participate in tolerance and autoimmunity through cytokine production, Autoimmunity, vol.45, issue.1, pp.1-12
DOI : 10.3109/08916934.2012.665527

J. M. Lykken, M. Kathleen, and T. F. Candando, Regulatory B10 cell development and function: Fig. 1., International Immunology, vol.27, issue.10, pp.471-477
DOI : 10.1093/intimm/dxv046

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817073

L. Madsen, P. Siim, S. Christophersen, and . Olesen, Blockade of Ca2+-activated K+ channels in T cells: an option for the treatment of multiple sclerosis?, European Journal of Immunology, vol.23, issue.4, pp.1023-1026, 2005.
DOI : 10.4049/jimmunol.166.2.936

D. Masson, J. Adèle, H. L. Bouaziz, and . Buanec, CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease, Blood, vol.125, issue.11, pp.1830-1839
DOI : 10.1182/blood-2014-09-599159

M. Matsumoto, A. Baba, and T. Yokota, Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation, Immunity, vol.41, issue.6, pp.1040-1051
DOI : 10.1016/j.immuni.2014.10.016

URL : http://doi.org/10.1016/j.immuni.2014.10.016

M. A. Maurer, G. Rakocevic, and C. S. Leung, Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity, Journal of Clinical Investigation, vol.122, issue.4, pp.1393-1402
DOI : 10.1172/JCI58743DS1

M. A. Maurer, F. Tuller, and V. Gredler, Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination, Journal of Neuroimmunology, vol.290, pp.49-53
DOI : 10.1016/j.jneuroim.2015.11.006

C. Mauri, A. Bosma-thèse-de-recherche-nicolas-berkani-messingham, N. Kelly, R. Srikantha, A. M. Degueme et al., FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid, Journal of Immunology, vol.187, issue.1, pp.553-560, 1950.

B. Moncada, S. Kettelsen, J. L. Hernández-moctezuma, and F. Ramirez, Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies, British Journal of Dermatology, vol.42, issue.4, pp.465-467, 1982.
DOI : 10.1159/000230636

V. Acetylglucosaminyltransferase and . Mgat5, Mediated N-Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells, Journal of Immunology, vol.173, issue.12, pp.7200-7208, 1950.

H. Mouquet, P. Musette, and M. Gougeon, B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses, Journal of Investigative Dermatology, vol.128, issue.12, pp.2859-2869, 2008.
DOI : 10.1038/jid.2008.178

D. L. Mueller, Mechanisms maintaining peripheral tolerance, Nature Immunology, vol.6, issue.1, pp.21-27
DOI : 10.4049/jimmunol.167.10.5636

M. Nakou, G. Katsikas, and P. Sidiropoulos, Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response, Arthritis Research & Therapy, vol.11, issue.4, p.131, 2009.
DOI : 10.1186/ar2798

K. C. Nelson, M. Zhao, and P. R. Schroeder, Role of different pathways of the complement cascade in experimental bullous pemphigoid, Journal of Clinical Investigation, vol.116, issue.11, pp.2892-2900, 2006.
DOI : 10.1172/JCI17891

P. Neves, V. Lampropoulou, and E. Calderon-gomez, Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection, Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella Typhimurium Infection, pp.777-790, 2010.
DOI : 10.1016/j.immuni.2010.10.016

M. Nielsen, J. Gerwien, and C. Geisler, LFA-3)-Mediated Adhesion in Human T Cells, MHC Class II Ligation Induces Experimental and Clinical Immunogenetics, vol.58, issue.152, pp.61-68, 1998.

W. Nishie, S. Lamer, and A. Schlosser, Ectodomain Shedding Generates Neoepitopes on Collagen XVII, the Major Autoantigen for Bullous Pemphigoid, The Journal of Immunology, vol.185, issue.8, pp.185-4938, 1950.
DOI : 10.4049/jimmunol.1001524

W. Nishie, D. Sawamura, and M. Goto, Humanization of autoantigen, Nature Medicine, vol.280, issue.3, pp.378-383, 2007.
DOI : 10.1002/1099-1387(200008)6:8<378::AID-PSC265>3.0.CO;2-Q

. Thèse-de-recherche-nicolas-berkani-ouchida, T. Rika, J. Kurosaki, and . Wang, Role for Lysosomal-Associated Protein Transmembrane 5 in the Negative Regulation of Surface B Cell Receptor Levels and B Cell Activation, Journal of Immunology, vol.185, issue.1, pp.294-301, 1950.

. Park, S. Jung-hyun, T. Adoro, and . Guinter, Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells, Nature Immunology, vol.163, issue.3, pp.257-264, 2010.
DOI : 10.1016/S0092-8674(00)80048-3

A. S. Payne, K. Ishii, and S. Kacir, Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display, Journal of Clinical Investigation, vol.115, issue.4, pp.888-899, 2005.
DOI : 10.1172/JCI24185

R. Pelanda, S. Schwers, and E. Sonoda, Receptor Editing in a Transgenic Mouse Model: Site, Efficiency, and Role in B Cell Tolerance and Antibody Diversification, Immunity, vol.7, issue.6, pp.765-775, 1997.
DOI : 10.1016/S1074-7613(00)80395-7

R. J. Petrie and J. P. , Colocalization of the B Cell Receptor and CD20 Followed by Activation-Dependent Dissociation in Distinct Lipid Rafts, The Journal of Immunology, vol.169, issue.6, pp.2886-2891, 1950.
DOI : 10.4049/jimmunol.169.6.2886

V. Picerno, F. Ferro, and A. Adinolfi, 2015 One Year in Review: The Pathogenesis of Rheumatoid Arthritis, Clinical and Experimental Rheumatology, vol.33, issue.4, pp.551-558

M. J. Polyak, H. Li, N. Shariat, and J. P. , CD20 Homo-oligomers Physically Associate with the B Cell Antigen Receptor, Journal of Biological Chemistry, vol.158, issue.27, pp.18545-18552
DOI : 10.1002/eji.1830240406

J. E. Pope and S. R. Johnson, New Classification Criteria for Systemic Sclerosis (Scleroderma) Rheumatic Diseases Clinics of, North America, vol.41, issue.3, pp.383-398, 2015.

D. Punwani, K. Simon, and Y. Choi, Transcription Factor Zinc Finger and BTB Domain 1 Is Essential for Lymphocyte Development, The Journal of Immunology, vol.189, issue.3, pp.1253-1264, 1950.
DOI : 10.4049/jimmunol.1200623

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401355

Y. Qian, L. A. Diaz, J. Ye, and S. H. Clarke, Dissecting the Anti-Desmoglein Autoreactive B Cell Repertoire in Pemphigus Vulgaris Patients, The Journal of Immunology, vol.178, issue.9, pp.5982-5990, 1950.
DOI : 10.4049/jimmunol.178.9.5982

M. Relle, J. Weinmann-menke, and E. Scorletti, Genetics and novel aspects of therapies in systemic lupus erythematosus, Autoimmunity Reviews, vol.14, issue.11, pp.1005-1018
DOI : 10.1016/j.autrev.2015.07.003

V. C. Rodríguez-cortez, L. Del-pino-molina, and J. Rodríguez-ubreva, Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during na?ve-to-memory B-cell transition, Nature Communications, vol.12, p.7335
DOI : 10.1093/bioinformatics/btn615

A. Roguedas, P. Youinou, G. Lemasson, Y. Pennec, and L. , Primary Gougerot-Sjogren syndrome: a dermatological approach, Journal of the European Academy of Dermatology and Venereology, vol.90, issue.3, pp.243-247
DOI : 10.1007/BF00683877

. Anti-cd20, Therapy in Patients with Rheumatoid Arthritis: Predictors of Response and B Cell Subset Regeneration after Repeated Treatment, Arthritis and Rheumatism, vol.58, issue.6, pp.1566-1575

A. Roussel, J. Benichou, and Z. Arivelo-randriamanantany, Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.293-298, 2011.
DOI : 10.1001/archdermatol.2011.21

E. J. Ryan, J. Aaron, D. Marshall, and . Magaletti, Dendritic Cell-Associated Lectin-1: A Novel Dendritic Cell-Associated, C-Type Lectin-Like Molecule Enhances T Cell Secretion of IL-4, The Journal of Immunology, vol.169, issue.10, pp.169-5638, 1950.
DOI : 10.4049/jimmunol.169.10.5638

S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic Self-Tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25) Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases, Journal of Immunology, vol.155, issue.3, pp.1151-1164, 1950.

J. R. Schiltz and B. Michel, Production Of Epidermal Acantholysis In Normal Human Skin In Vitro By The Igg Fraction From Pemphigus Serum, Journal of Investigative Dermatology, vol.67, issue.2, pp.254-260, 1976.
DOI : 10.1111/1523-1747.ep12513454

E. Schmidt and D. , Diagnosis and Treatment of Patients with Autoimmune Bullous Disorders in Germany, Dermatologic Clinics, vol.29, issue.4, pp.663-671
DOI : 10.1016/j.det.2011.06.007

E. Schmidt, K. Obe, E. B. Bröcker, and D. , Zillikens 2000 Serum Levels of Autoantibodies to BP180 Correlate with Disease Activity in Patients with Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, pp.174-178

. Thèse-de-recherche-nicolas-berkani, E. Schmidt, S. Reimer, and N. Kruse, Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes, The Journal of Investigative Dermatology, vol.115, issue.5, pp.842-848, 2000.

M. Sekiguchi, Y. Futei, and Y. Fujii, Dominant Autoimmune Epitopes Recognized by Pemphigus Antibodies Map to the N-Terminal Adhesive Region of Desmogleins, The Journal of Immunology, vol.167, issue.9, pp.5439-5448, 1950.
DOI : 10.4049/jimmunol.167.9.5439

I. Shalev, M. Schmelzle, S. C. Robson, and G. Levy, Making sense of regulatory T cell suppressive function, Seminars in Immunology, vol.23, issue.4, pp.282-292, 2011.
DOI : 10.1016/j.smim.2011.04.003

P. Shen, T. Roch, and V. Lampropoulou, IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.42, issue.7492, pp.366-370
DOI : 10.1002/eji.201142242

S. Shetty and A. , Razzaque Ahmed 2013 Treatment of Bullous Pemphigoid with Rituximab: Critical Analysis of the Current Literature, Journal of Drugs in Dermatology: JDD, vol.12, issue.6, pp.672-677

G. P. Shi, R. A. Bryant, and R. Riese, Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages, The Journal of Experimental Medicine, vol.161, issue.7, pp.1177-1186, 2000.
DOI : 10.1084/jem.188.4.725

S. Shiraishi, T. Iio, and Y. Shirakata, Bullous pemphigoid in a patient with a C4 deficiency, British Journal of Dermatology, vol.52, issue.3, pp.296-298, 1991.
DOI : 10.1111/1523-1747.ep12283737

S. Sigurdsson, H. H. Göring, and G. Kristjansdottir, Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus, Human Molecular Genetics, vol.17, issue.6, pp.872-881, 2008.
DOI : 10.1093/hmg/ddm359

S. Sigurdsson, L. Padyukov, and F. A. Kurreeman, Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis, Arthritis & Rheumatism, vol.54, issue.7, pp.2202-2210, 2007.
DOI : 10.4049/jimmunol.173.4.2815

J. E. Smith-garvin, A. Gary, M. S. Koretzky, and . Jordan, T Cell Activation, Annual Review of Immunology, vol.27, issue.1, pp.591-619, 2009.
DOI : 10.1146/annurev.immunol.021908.132706

J. R. Somoza, T. James, J. D. Palmer, and . Ho, The Crystal Structure of Human Cathepsin F and Its Implications for the Development of Novel Immunomodulators, Journal of Molecular Biology, vol.322, issue.3, pp.559-568, 2002.
DOI : 10.1016/S0022-2836(02)00780-5

C. F. Spurlock, T. John, N. J. Tossberg, and T. M. Olsen, T Cells in Rheumatoid Arthritis Is Genetically Determined by HLA Risk Alleles, The Journal of Immunology, vol.195, issue.3, pp.791-795, 1950.
DOI : 10.4049/jimmunol.1500267

. Thèse-de-recherche-nicolas-berkani-sun, C. Jia-bin, C. Flach, and . Czerkinsky, B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit, Journal of Immunology, issue.12, pp.181-8278, 1950.

J. A. Sutter, J. Kwan-morley, and J. Dunham, A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery, Clinical Immunology, vol.126, issue.3, pp.282-290, 2008.
DOI : 10.1016/j.clim.2007.11.012

H. Takahashi, M. Kuwana, and M. Amagai, A Single Helper T Cell Clone Is Sufficient to Commit Polyclonal Naive B Cells to Produce Pathogenic IgG in Experimental Pemphigus Vulgaris, The Journal of Immunology, vol.182, issue.3, pp.1740-1745, 1950.
DOI : 10.4049/jimmunol.182.3.1740

J. L. Teeling, R. Ruth, M. S. French, and . Cragg, Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas, Characterization of New Human CD20 Monoclonal Antibodies with Potent Cytolytic Activity against Non-Hodgkin Lymphomas, pp.1793-1800, 2004.
DOI : 10.1182/blood-2004-01-0039

Y. K. Teng, J. Tekstra, and F. C. Breedveld, Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.1075-1077, 2009.
DOI : 10.1136/ard.2008.100438

R. Valdor and F. , Induction and stability of the anergic phenotype in T cells, Seminars in Immunology, vol.25, issue.4, pp.313-320
DOI : 10.1016/j.smim.2013.10.010

G. Vattemi, M. Marini, and M. Di-chio, Polymyositis in solid organ transplant recipients receiving tacrolimus, Journal of the Neurological Sciences, vol.345, issue.1-2, pp.239-243
DOI : 10.1016/j.jns.2014.07.036

C. A. Walshe, A. Stephen, R. R. Beers, and . French, Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling, Journal of Biological Chemistry, vol.169, issue.Suppl. 2, pp.16971-16984, 2008.
DOI : 10.4049/jimmunol.169.6.2886

R. Wang, C. Yu, and I. M. Dambuza, Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Interleukin-35 Induces Regulatory B Cells That Suppress Autoimmune Disease, pp.633-641, 2014.
DOI : 10.1074/jbc.M111.253500

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048323

A. D. Wells, New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting, The Journal of Immunology, vol.182, issue.12, pp.7331-7341, 1950.
DOI : 10.4049/jimmunol.0803917

J. J. Worthington, A. Kelly, and C. Smedley, Integrin ?v?8-Mediated TGF-? Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation, Immunity, vol.42, issue.5, pp.903-915
DOI : 10.1016/j.immuni.2015.04.012

. Thèse-de-recherche-nicolas-berkani-yanaba, J. Koichi, K. M. Bouaziz, and . Haas, A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell- Dependent Inflammatory Responses, Immunity, vol.28, issue.5, pp.639-650, 2008.

L. Yan, J. Wang, and K. , Zeng 2012 Association between HLA-DRB1 Polymorphisms and Pemphigus Vulgaris: A Meta-Analysis

S. Yayli, N. Pelivani, and H. Beltraminelli, Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis, British Journal of Dermatology, vol.162, issue.5, pp.1133-1137, 2011.
DOI : 10.1111/j.1365-2133.2009.09508.x

T. Yokoyama, S. Matsuda, and Y. Takae, Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris, International Immunology, vol.23, issue.6, pp.365-373, 2011.
DOI : 10.1093/intimm/dxr020

A. Yoshizaki, T. Miyagaki, and D. J. Dilillo, Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, Nature, vol.3, issue.7423, pp.264-268
DOI : 10.1038/ni833

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493692

D. Zillikens, P. A. Rose, and S. D. Balding, Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-579, 1997.
DOI : 10.1111/1523-1747.ep12337492

C. Zwick and N. Murawski, Rituximab in High-Grade Lymphoma, Seminars in Hematology, vol.47, issue.2, pp.148-155
DOI : 10.1053/j.seminhematol.2010.01.008